Clinical Trials Directory

Trials / Completed

CompletedNCT04813679

Bed-side Ultrasound in Neutropenic Enterocolitis

Bed-side Ultrasound in the Evaluation of Gastro-intestinal Tract and Neutropenic Enterocolitis (NEC) in Neutropenic Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
1,740 (actual)
Sponsor
Azienda Ospedaliero, Universitaria Pisana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neutropenic enterocolitis (NEC) is a life-threatening complication of leukemic and solid tumors patients (pts) treated with chemotherapy (CHT) with high mortality rate up to 50-100%. Perforation occurs in 5%-10% of cases. Early diagnosis is crucial to start conservative medical management (CMM), which appears the optimal strategy for most cases. NEC should be always suspected in Neutropenic pts with abdominal pain, fever and diarrhea. Ultrasound (US) can be used to evaluate bowel-wall thickening (BWT). The objective of this study is to evaluate prospectively if US can detect early signs of NEC and guide a prompt treatment (CMM or surgical) and thus reduce mortality.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBed side Ultrasound SonographyBed side Ultrasound in Neutropenic patients within 12 h from onset of any symptom such as fever and/or abdominal pain and/or diarreha

Timeline

Start date
2007-03-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2021-03-24
Last updated
2021-03-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04813679. Inclusion in this directory is not an endorsement.